← back to search

Renata Zaucha

Karachi Institute of Radiotherapy and Nuclear Medicine · PL
Area of research
Oncology · Surgery
Research interest
Research interests include Cancer Immunotherapy and Biomarkers, Lymphoma Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies, and Inflammatory Biomarkers in Disease Prognosis.
h-index
22
citations
3,757
works
111
NIH funding
—
primary concept
Medicine
email
renata.zaucha@gmail.com

Recent publications

Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study
˜The œLancet. Gastroenterology & hepatology 2024cited by 235position: middledoi
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer
NEJM Evidence 2022cited by 1,058position: middledoi
A phase 3 randomized, double-blind, placebo-controlled study of durvalumab in combination with gemcitabine plus cisplatin (GemCis) in patients (pts) with advanced biliary tract cancer (BTC): TOPAZ-1.
Journal of Clinical Oncology 2022cited by 234position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Shukui Qin · People's Liberation Army No. 150 Hospital1 papers (2022–2022)Mohamed Bouattour · Cereep Ecotron Île-de-France1 papers (2022–2022)Antonio Avallone · Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale"1 papers (2022–2022)Jin Won Kim · Chonnam National University1 papers (2022–2022)Li‐Tzong Chen · Kaohsiung Medical University1 papers (2022–2022)Julia Xiong · AstraZeneca (United States)1 papers (2022–2022)Nana Rokutanda · AstraZeneca (Netherlands)1 papers (2022–2022)Juan Cundom · Instituto de Diagnóstico e Investigaciones Metabólicas1 papers (2022–2022)Thatthan Suksombooncharoen · Maharaj Nakorn Chiang Mai Hospital1 papers (2022–2022)Gordon Cohen · AstraZeneca (United States)1 papers (2022–2022)Suebpong Tanasanvimon · University of Edinburgh1 papers (2022–2022)Myung Ah Lee · The Catholic University of Korea Seoul St. Mary's Hospital1 papers (2022–2022)Aiwu Ruth He · Columbia University Irving Medical Center1 papers (2022–2022)Do‐Youn Oh · New Generation University College1 papers (2022–2022)Masayuki Kitano · The Japanese Society of Gastroenterological Surgery1 papers (2022–2022)Howard A. Burris · Sarah Cannon1 papers (2022–2022)Takuji Okusaka · National Cancer Center1 papers (2022–2022)Juan W. Valle · Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele1 papers (2022–2022)Arndt Vogel · Federal Institute for Risk Assessment1 papers (2022–2022)